Lensar (LNSR) Cash from Financing Activities (2019 - 2026)
Lensar (LNSR) reported Cash from Financing Activities of -$209000.0 for Q1 2026, down 102.16% year-over-year from $9.7 million in Q1 2025, and down 144.09% on a QoQ basis from $474000.0 in Q4 2025.
Lensar (LNSR) has 8 years of Cash from Financing Activities data on file, last reported at -$209000.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 102.16% year-over-year to -$209000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $358000.0 (down 96.38% YoY) and the FY2025 annual result came in at $10.3 million, up 13051.28% from the prior year.
- Cash from Financing Activities retreated to -$209000.0 in Q1 2026 per LNSR's latest filing, from $474000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $9.7 million in Q1 2025 and bottomed at -$1.2 million in Q3 2022.
- The 5-year median for Cash from Financing Activities is $111000.0 (2024), against an average of $755333.3.
- The widest annual swing landed in 2025, when Cash from Financing Activities soared 7554.62%; it then sank 102.16% in 2026.
- Tracing LNSR's Cash from Financing Activities over 5 years: stood at $196000.0 in 2022, then retreated by 25.51% to $146000.0 in 2023, then gained by 17.81% to $172000.0 in 2024, then soared by 175.58% to $474000.0 in 2025, then plunged by 144.09% to -$209000.0 in 2026.
- Per Business Quant, the three latest LNSR Cash from Financing Activities figures stand at -$209000.0 (Q1 2026), $474000.0 (Q4 2025), and $93000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | -209,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -209,000.00 |
| Mar 31, 2026 | -209,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | 9.69 Mn |
| Mar 31, 2025 | 9.69 Mn |
| Dec 31, 2024 | 172,000.00 |
| Dec 31, 2024 | 172,000.00 |
| Sep 30, 2024 | -93,000.00 |
| Sep 30, 2024 | -93,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Mar 31, 2024 | -130,000.00 |
| Mar 31, 2024 | -130,000.00 |
| Dec 31, 2023 | 146,000.00 |
| Dec 31, 2023 | 146,000.00 |
| Sep 30, 2023 | -205,000.00 |
| Sep 30, 2023 | -205,000.00 |
| Dec 31, 2022 | 196,000.00 |
| Dec 31, 2022 | 196,000.00 |
| Sep 30, 2022 | -1.20 Mn |
| Sep 30, 2022 | -1.20 Mn |
| Dec 31, 2021 | 191,000.00 |
| Dec 31, 2021 | 191,000.00 |
| Sep 30, 2020 | 37.93 Mn |
| Sep 30, 2020 | 37.93 Mn |
| Jun 30, 2020 | 7.69 Mn |
| Jun 30, 2020 | 7.69 Mn |
| Mar 31, 2020 | 4.38 Mn |
| Mar 31, 2020 | 4.38 Mn |
| Dec 31, 2019 | 10.20 Mn |
| Dec 31, 2019 | 10.20 Mn |